Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The new $NSAV CEX Rewards Platform will benefit shareholders in numerous ways. All existing and verified $NSAV shareholders will be eligible for a wallet and receive reward tokens simply for registering and future reward tokens for years to come.
— NSAV Holding (@NSAV_Tech) November 3, 2023
And finally for this morning, at the end of the day, we will have a major update regarding $NSAV's revolutionary crypto hacking solution, TruSAF https://t.co/JVv7pgycez . So, please stay tuned. Thank you.
— NSAV Holding (@NSAV_Tech) November 3, 2023
NSAV X recap!
Good morning $NSAV shareholders. We hope we answered at least some of your important questions with our tweets yesterday. The Company will do our best to keep our shareholders informed on a regular basis, especially on material issues.
— NSAV Holding (@NSAV_Tech) November 3, 2023
In case you missed our after hours tweets yesterday, $NSAV's joint-venture CEX (Centralized Cryptocurrency Exchange), https://t.co/afixJsWUdN . will be renamed for the $NSAV Rewards Platform and will list all existing $NSAV tokens, including our NSBC token, which many of you own.
— NSAV Holding (@NSAV_Tech) November 3, 2023
NSAV X recap!
Good morning $NSAV shareholders. We hope that you all had a great holiday weekend.
— NSAV Holding (@NSAV_Tech) October 10, 2023
In the event that you missed it due to the holiday, please see the link below to view yesterday's press release on the progress of $NSAV's TruSAF, a revolutionary crypto hacking solution, including the spectacular tutorial video https://t.co/JVv7pgycez .https://t.co/DKDcXD0UQS
— NSAV Holding (@NSAV_Tech) October 10, 2023
Now that the extraordinary TruSAF https://t.co/JVv7pgycez project is progressing smoothly, it's time to locate, sign and close additional major deals and that is what $NSAV is doing.
— NSAV Holding (@NSAV_Tech) October 10, 2023
$NSAV has just signed another major deal. What we can say for now is that as part of the deal, $NSAV has onboarded new seasoned BIPOC executives as minority shareholders, who will assist in guiding the company to new heights. Further details will be announced shortly.
— NSAV Holding (@NSAV_Tech) October 10, 2023
https://www.otcmarkets.com/stock/NSAV/news/NSAV-Announces-Advancement-in-Revolutionary-Crypto-Hacking-Solution-TruSAF?id=416792
NSAV Announces Advancement in Revolutionary Crypto Hacking Solution, TruSAF
Press Release | 10/09/2023
Net Savings Link, Inc. (OTC: NSAV), a cryptocurrency, blockchain and digital asset technology company, announced today major progress in TruSAF, including the long-awaited TruSAF tutorial video, which is now live and can be viewed on our TruSAF website https://trusaf.net/ . The TruSAF website has also undergone a major upgrade and
will continue to be enhanced and customized as required.
TruSAF is a revolutionary Crypto Hacking Solution. TruSAFs breakthrough solution is the First and Only of its kind and intended to be a permanent solution to the crypto hacking problem. TruSAF achieves this through a groundbreaking advancement in data security technology that keeps ones digital assets off the grid, while also providing the ability to access them at any given time. In 2022, the crypto industry lost nearly $4 billion due to hacking.
https://nftevening.com/crypto-industry-lost-3-78b-in-over-300-hacks-in-2022-report/#:~:text=By%20Reethu%20Ravi%20January%2010%2C%202023%20Updated%3A%20February,303%20security%20incidents%2C%20compared%20to%20236%20in%202021
NSAVs TruSAF solves a large-scale problem across all industries security of digital assets, legal documents and sensitive medical information. TruSAF encompasses three main components; CryptoSAF, DocuSAF and MedSAF. In addition to the billions of dollars lost each year due to Crypto Hacking, reports evidence 4 million sensitive documents being stolen every hour and $1 Billion of medical information sold every day. NSAV is in the process of preparing a tutorial video, which will show how extraordinary TruSAF really is.
The management of NSAV released the following statement, We are thrilled with the progress of TruSAF in such a short period of time. We are equally delighted with the TruSAF video, which will now allow the world to see how remarkable TruSAF really is.
NSAV's vision is the establishment of a fully integrated technology company, which provides turnkey technological solutions to the cryptocurrency, blockchain and digital asset industries. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, financial services, advisory services and information technology.
For further information please contact NSAV at info@nsavholdinginc.com
The NSAV Twitter account can be accessed at https://twitter.com/nsav_tech
The NSAV corporate website can be accessed at http://nsavholdinginc.com
The NSAV Centralized Cryptocurrency Exchange (CEX) website can be accessed at https://ex.nsavexchange.com/main
The NSAV CEX Twitter account can be accessed at https://twitter.com/nsavcex
The NSAVDEX 1 Exchange website can be accessed at https://nsavdex.org/#/home
The NSAVDEX 2 Exchange website can be accessed at https://nsavdex.io/
The NSAV Premium OTC Crypto Trading Desk website can be accessed at https://nsavholdinginc.com/otc-desk/
The NSAV Hong Kong OTC Crypto Trading Desk website can be accessed at
https://hkotc.co/
The NSAVDEX Exchange Telegram account can be accessed at https://t.me/NSAVDEXorg
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person.
Contact
Net Savings Link, Inc.
info@nsavholdinginc.com
NSAV X recap!
Good morning $NSAV shareholders. We hope that you are having a great holiday weekend.
— NSAV Holding (@NSAV_Tech) October 9, 2023
We would like to sincerely thank the $NSAV shareholders who submitted AMA questions. We will be answering your questions as time permits and the answers will appear on the Telegram Channel (TG) below. Thank you.https://t.co/LKhfReXQzC
— NSAV Holding (@NSAV_Tech) October 9, 2023
$MRES$
https://www.otcmarkets.com/stock/MRES/news/M2Bio-Discovery-Centre-for-AI-Driven-Phytomedicine-Research-Update?id=414016
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
Press Release | 09/13/2023
CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 13, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative plant-based cannabinoids, medical psilocybin, and cutting-edge mental health therapeutic research driven by artificial intelligence (AI), is pleased to present a groundbreaking update on its latest scientific endeavor:
M2Bio Sciences endeavors to usher in a paradigm shift within the realm of medical health by focusing on the foundational facet of drug discovery. Historically, pharmaceutical development has been indispensable in addressing various medical conditions, from combating bacterial pathogens to mitigating cardiovascular diseases. However, the drug discovery process has been characterized by exorbitant costs, protracted timelines, and ethical considerations involving animal and human trials. In light of the maturation of artificial intelligence, particularly in the domain of general AI, M2Bio posits that this process can be substantially expedited and rendered more cost-effective, with minimal ethical implications, through the utilization of machine learning (ML) models and mature general AI algorithms.
M2Bio Sciences has appointed Ze-ev Krein, an interdisciplinary scientist, and M2Bio Scientific Advisory Board Chairman, to spearhead this pioneering research initiative. Mr. Krein possesses a unique blend of expertise encompassing drug discovery, computer science, and legal background, which includes familiarity with compliance and the legal intricacies associated with drug research and discovery.
Krein, under the tutelage of Prof. Maharaj at the University of Pretoria, will conduct research that contributes both to M2Bio's drug discovery program and to his doctorate, focusing on the most advanced applications of AI in drug discovery. M2Bio will retain the intellectual property and commercial rights for the lead compounds, while the center will actively collaborate with numerous institutions and researchers to foster progress through open-source and joint venture collaborations. Updates on research progress will be periodically disseminated through M2Bio's various media channels.
M2Bio Sciences continues to make substantial investments in AI, which constitutes a fundamental pillar of the company's holistic health approach. The primary application of AI within this framework is as follows:
#1 Drug Discovery Advancement: Artificial Intelligence (AI) harnesses the capacity to scrutinize extensive datasets for the purpose of discerning potential drug candidates. Machine learning models have the capability to prognosticate molecular interactions with precise biological targets, thereby expediting the process of unearthing compounds imbued with therapeutic potential. This facet of AI proves particularly instrumental during target identification and lead optimization phases.
#2 Drug Repurposing Excellence: AI scrutinizes established pharmaceutical agents and their well-documented mechanisms of action, affording the capacity to uncover novel therapeutic utilities for these compounds. This invaluable function not only economizes valuable time and resources but also enables the repurposing of existing agents to treat diverse maladies.
#3 Proficiency in Predicting Drug Toxicity: AI models demonstrate proficiency in anticipation of potential drug toxicity by means of an exhaustive analysis of chemical structures and biological data. The early identification of toxic compounds within the developmental trajectory averts the considerable costs and setbacks associated with late-stage failures.
#4 Precision in Clinical Trial Optimization: AI stands as a powerful tool in the optimization of clinical trial design, adept at identifying apt patient cohorts, forecasting patient responses, and contributing to the formulation of more streamlined and cost-effective clinical trials. This orchestration leads to expeditious drug approval processes.
#5 Excellence in Drug Manufacturing: AI is pivotal in enhancing drug manufacturing processes, ensuring consistent product quality, and diminishing production costs. AI's predictive capabilities also safeguard against manufacturing issues that may precipitate batch failures.
#6 Foretelling Drug Interaction and Adverse Events: AI, through its analysis of patient data, possesses the capacity to predict potential drug interactions and foresee adverse events, thereby empowering healthcare professionals to make judicious and informed treatment determinations.
#7 Pioneering Drug Target Identification: AI adeptly navigates through extensive biological datasets, facilitating the identification of innovative drug targets, a crucial component in developing therapeutics designed to address hitherto refractory diseases.
#8 Innovating Drug Delivery Systems: AI is pivotal in designing avant-garde drug delivery systems, thereby enhancing drug efficacy and concurrently reducing deleterious side effects.
#9 Tailored Medicine Through AI: AI's analytical prowess extends to the personalization of drug regimens, drawing from patient-specific data, including genetic information, in a field referred to as pharmacogenomics. This tailored approach augments treatment outcomes while mitigating adverse reactions.
#10 Regulatory Compliance via AI: AI lends a helping hand to pharmaceutical enterprises in assuring adherence to stringent regulatory standards throughout the drug development process. This proactive involvement mitigates the risk of approval delays.
#11 Strategic Drug Pricing and Market Access: AI leverages its analytical capabilities to scrutinize comprehensive market data, pricing structures, and patient outcomes, providing invaluable insights for shaping drug pricing strategies and determining market access approaches.
#12 Insights Through Drug Data Mining: AI mines vast reservoirs of scientific literature, clinical trial data, and patient records to unearth novel insights that have the potential to inform and shape drug development strategies.
#13 Automation in Drug Discovery: AI-driven robotic systems stand at the vanguard of innovation in automating high-throughput compound screening for drug discovery, thereby ushering in a substantial enhancement in the efficiency of this pivotal process.
The potential applications of AI in drug discovery are virtually boundless. M2Bio leverages nature's wealth to expedite discovery, specifically the synthesis of natural products. While synthesizing natural products poses significant challenges, plants have co-evolved with human organisms, yielding many complex bioactive molecules. Accordingly, M2Bio plans to harness various African plants, known for their biologically active compounds, to identify potential phytochemicals or lead compounds for pharmaceutical development. M2Bio has made substantial financial commitments to the University of Pretoria, a prestigious institution in the South African capital, to extract and characterize these compounds. M2Bio will establish and manage a comprehensive database of these lead compounds, with extraction conducted at its newly established research laboratory at the University: M2Bio-Discovery Centre for AI-Driven Phytomedicine Research. AI algorithms will be employed to expedite the characterization and identification process exponentially. This pioneering initiative represents a significant milestone for Africa.
"Embarking on this scientific journey, we stand at the precipice of a profound transformation in drug discovery. Leveraging the formidable capabilities of artificial intelligence to decode the intricate language of nature found within the compounds of African flora, we are pioneering a path that promises to revolutionize pharmaceutical research and underscores the vital importance of ecological partnerships in scientific innovation. This endeavor embodies a fusion of cutting-edge AI technology and the wisdom of natural ecosystems, marking a scientifically paramount milestone in our quest to advance human health." said Ze-ev Krein.
Jeff Robinson, Chairman and CEO of M2Bio Sciences, added: "Our Team, vision, and mission continue to get stronger and stronger each and every day. It's incredibly rewarding to provide the tools to all the team members at M2Bio Sciences and watch them grow daily."
About Institute of Biomedical Research Corp./ DBA M2Bio Sciences
Institute of Biomedical Research Corp is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, Liviana™ brands as well as artificial intelligence-powered nutrition products and solutions under the M2Biome brand. In addition, our research and clinical trials with psilocybin are aimed at new therapies to help patients suffering from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies such as artificial intelligence.
The Company is traded on the Over-the-Counter Bulletin Board of NASDAQ under the trading symbol "MRES".
Publicly traded Company (OTC Pink:MRES)
www.m2bio.co
jeff@m2bio.co
+27 72 333 2148
Find M2Bio™ on social media
Facebook: M2Bio
Instagram: M2bio.Sciences
LinkedIn: M2Bio
Twitter: @M2bio
Forward-Looking Statements
Safe Harbour Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences to include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency, and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
SOURCE: Institute of BioMedical Research Corp.
View source version on accesswire.com:
https://www.accesswire.com/783670/m2bio-discovery-centre-for-ai-driven-phytomedicine-research-update
NSAV X recap!
Good morning $NSAV shareholders. Late yesterday, we received an email from OTC Markets with a comment regarding our June 30, 2023 quarterly report. As is their new procedure, they put a yield sign on almost immediately. We have already filed the amended report we OTC Markets.
— NSAV Holding (@NSAV_Tech) August 31, 2023
$NSAV will have the yield sign removed by OTC Markets shortly and will be back to Pink Current. https://t.co/KCnNZHJH0g
— NSAV Holding (@NSAV_Tech) August 31, 2023
In addition to the TruSAF https://t.co/JVv7pgycez crypto hacking solution tutorial video and related IPO and the FUNGY NFT Marketplace on the way, $NSAV has several more exciting acquisitions and projects ready to go, so please stay tuned for further details.
— NSAV Holding (@NSAV_Tech) August 31, 2023
NSAV X recap!
Good morning $NSAV shareholders. Management realizes that it has been a difficult few days for all of you. Many shareholders have asked about some false rumors regarding TruSAV https://t.co/JVv7pgycez . TruSAF is happening and the tutorial video is now undergoing its first edit.
— NSAV Holding (@NSAV_Tech) August 29, 2023
The TruSAF tutorial video will be completed and released shortly. Stay tuned.
— NSAV Holding (@NSAV_Tech) August 29, 2023
Many of you have asked how the TruSAF IPO will benefit them. $NSAV will still retain roughly 80% of the TruSAF shares after the IPO. The IPO will raise money to grow TruSAF and the 80% of the shares that $NSAV retains in TruSAF will be more valuable as part of a public company.
— NSAV Holding (@NSAV_Tech) August 29, 2023
The TruSAF IPO will not only enhance the value of TruSAF, but in turn also enhance the value of $NSAV and therefore benefit all $NSAV shareholders. Management also foresees additional ways that the TruSAF IPO will benefit our shareholders, so stay tuned.https://t.co/JVv7pgycez
— NSAV Holding (@NSAV_Tech) August 29, 2023
You are welcome…GLTUA!
NSAV X recap!
Good morning $NSAV shareholders. As stated in our press release from August 4 and inline with $NSAV acquiring a significant 40% stake in the FUNGY NFT marketplace, the exchange is undergoing a major upgrade and will be back live shortly.
— NSAV Holding (@NSAV_Tech) August 18, 2023
In the meantime, and as many $NSAV shareholders are not familiar with the FUNGY NFT marketplace, please view the official trailer at the link below. https://t.co/JYXmSldt2O
— NSAV Holding (@NSAV_Tech) August 18, 2023
$NSAV shareholders, please view this short video at the link below, which explains our FUNGY NFT's competitive advantage.https://t.co/57jUADmc0y
— NSAV Holding (@NSAV_Tech) August 18, 2023
$NSAV shareholders, the first official step in the TruSAF Corporation https://t.co/JVv7pgycez IPO, is registering the TruSAF shares with our longtime transfer agent Pacific Stock Transfer. Stay tuned for more on the upcoming IPO.
— NSAV Holding (@NSAV_Tech) August 18, 2023
While many $NSAV shareholders are very familiar with Pacific Stock Transfer, they may not be aware that in 2022, Pacific was purchased by blockchain powerhouse, Securitize. Please view their website at the link below. https://t.co/ioRIoBmRLH
— NSAV Holding (@NSAV_Tech) August 18, 2023
The acquisition of Pacific Stock Transfer by Securitize, should mean many more profitable opportunities for $NSAV and its shareholders.https://t.co/gJOHmG2rUO
— NSAV Holding (@NSAV_Tech) August 18, 2023
NSAV X recap!
Good morning $NSAV shareholders. As stated in our press release from August 4 and inline with $NSAV acquiring a significant 40% stake in the FUNGY NFT marketplace, the exchange is undergoing a major upgrade and will be back live shortly.
— NSAV Holding (@NSAV_Tech) August 18, 2023
In the meantime, and as many $NSAV shareholders are not familiar with the FUNGY NFT marketplace, please view the official trailer at the link below. https://t.co/JYXmSldt2O
— NSAV Holding (@NSAV_Tech) August 18, 2023
$NSAV shareholders, please view this short video at the link below, which explains our FUNGY NFT's competitive advantage.https://t.co/57jUADmc0y
— NSAV Holding (@NSAV_Tech) August 18, 2023
$NSAV shareholders, the first official step in the TruSAF Corporation https://t.co/JVv7pgycez IPO, is registering the TruSAF shares with our longtime transfer agent Pacific Stock Transfer. Stay tuned for more on the upcoming IPO.
— NSAV Holding (@NSAV_Tech) August 18, 2023
While many $NSAV shareholders are very familiar with Pacific Stock Transfer, they may not be aware that in 2022, Pacific was purchased by blockchain powerhouse, Securitize. Please view their website at the link below. https://t.co/ioRIoBmRLH
— NSAV Holding (@NSAV_Tech) August 18, 2023
The acquisition of Pacific Stock Transfer by Securitize, should mean many more profitable opportunities for $NSAV and its shareholders.https://t.co/gJOHmG2rUO
— NSAV Holding (@NSAV_Tech) August 18, 2023
NSAV X recap!
Good morning $NSAV shareholders. Just a brief update on our truly revolutionary crypto hacking solution, TruSAF https://t.co/0bLXFiaztN . The content for the tutorial video is now complete and we will be going into production in the coming days. So, please stay tuned.
— NSAV Holding (@NSAV_Tech) August 17, 2023
As previously announced, due to overwhelming interest from the investment and business community, the management of $NSAV has decided to take TruSAF public via an IPO (Initial Public Offering). We have already begun talks with a major global investment banking firm based in Dubai
— NSAV Holding (@NSAV_Tech) August 17, 2023
The Company anticipates formally engaging the Dubai investment banking firm in the coming week. The plan is to have them structure the TruSAF IPO. In our discussion yesterday, we came up with a strategy that will truly benefit all 30K $NSAV shareholders.https://t.co/JVv7pgycez
— NSAV Holding (@NSAV_Tech) August 17, 2023
Good morning $NSAV shareholders. Just a brief update on our truly revolutionary crypto hacking solution, TruSAF https://t.co/0bLXFiaztN . The content for the tutorial video is now complete and we will be going into production in the coming days. So, please stay tuned.
— NSAV Holding (@NSAV_Tech) August 17, 2023
Due to overwhelming interest from the investment and business community, the management of $NSAV has decided to take TruSAF public via an IPO (Initial Public Offering). The process has already begun and the subsidiary has been formed. https://t.co/JVv7pgycez
— NSAV Holding (@NSAV_Tech) August 2, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. Just a brief update on our truly revolutionary crypto hacking solution, TruSAF https://t.co/JVv7pgycez . The team is working overtime preparing the previously announced tutorial video, which will show how amazing TruSAF really is. So stayed tuned.
— NSAV Holding (@NSAV_Tech) August 2, 2023
We'll have another exciting update on TruSAF in a moment. Still to come this week is a major press release disclosing full details of $NSAV's most recent acquisition, a 40% stake in a state-of-the-art NFT exchange.
— NSAV Holding (@NSAV_Tech) August 2, 2023
$NSAV$$
🚨NEW PRESS RELEASE: $NSAV is pleased to announce the unveiling of revolutionary crypto hacking solution, TruSAF. Read the full release here:
NSAV Announces Unveiling of Revolutionary Crypto Hacking Solution, TruSAF
Press Release | 07/28/2023
Net Savings Link, Inc. (OTC: NSAV), a cryptocurrency, blockchain and digital asset technology company, announced today the unveiling of TruSAF https://trusaf.net/ , a revolutionary Crypto Hacking Solution. TruSAFs breakthrough solution is the First and Only of its kind and intended to be a permanent solution to the crypto hacking problem. TruSAF achieves this through a groundbreaking advancement in data security technology that keeps ones digital assets off the grid, while also providing the ability to access them at any given time. In 2022, the crypto industry lost nearly $4 billion due to hacking.
https://www.otcmarkets.com/stock/NSAV/news/NSAV-Announces-Unveiling-of-Revolutionary-Crypto-Hacking-Solution-TruSAF?id=409055
You are welcome XMAN…GLTUA
🚨NEW PRESS RELEASE: $NSAV is pleased to announce the unveiling of revolutionary crypto hacking solution, TruSAF. Read the full release here:https://t.co/jwf2jBlye8
— NSAV Holding (@NSAV_Tech) July 28, 2023
That’s what I’m talking about not only words but proof to back it up. GLTUA!
In due time patience will reward!
Top of the morning to you Thunderstruck. Smart move it’s brewing. GLTUA!
Happy Monday to all. Travel day for Jeff✈️ Off to Nairobi, Kenya. He is excited to meet and visit with government officials, tea and coffee companies, Universities and the plantations. 🫖☕$MRES @M2Biome He arrives late Monday evening. Wishing everybody a super Monday! pic.twitter.com/MhYMEMTTFk
— M2Bio Sciences (@m2bio) July 24, 2023
https://t.co/iOSuHHtfcf $MRES #Longevity @M2Biome
— M2Bio Sciences (@m2bio) July 24, 2023
'DNA diet' discovery paves the way for 'personalized' weight loss menu https://t.co/6v7fZ2mY2x via @nypost @m2bio
— M2Biome Cardiometabolic Health - Division of $MRES (@M2Biome) July 24, 2023
$mres Medspresso and Liviana products are in store shelves folks.. pic.twitter.com/u4ccCUKZhV
— widgetinvestor (@jdcpa123) July 22, 2023
Diagnosis of Viral Hepatitis Is Still a Major Challenge https://t.co/BcM5UhKzCn via @medscape
— M2Bio Sciences (@m2bio) July 23, 2023
NSAV Tweets recap!
Good afternoon $NSAV shareholders. Just a brief update on our truly revolutionary crypto hacking solution, TruSAF. We are in the process of preparing a tutorial video, which will show how amazing TruSAF really is. So stayed tuned.https://t.co/JVv7pgycez
— NSAV Holding (@NSAV_Tech) July 18, 2023
The management of $NSAV believes TruSAF will go a long way to solving the nearly $4 billion in crypto hacking losses annually.
— NSAV Holding (@NSAV_Tech) July 18, 2023
$NSAV has agreed to terms on a major crypto acquisition. This opportunity was presented to us only in the past two weeks. We expect to have the definitive acquisition agreement signed by the end of this week, or the beginning of next week, with a major press release to follow.
— NSAV Holding (@NSAV_Tech) July 18, 2023
$NSAV management believes this latest acquisition has a great synergy with our revolutionary crypto hacking solution and the integration could create a compelling combination. More on this exciting opportunity in the coming days.
— NSAV Holding (@NSAV_Tech) July 18, 2023
Tweeting
M2Bio Tweet!
Purple Tea, White Tea and Green Tea - Kenya, We are coming for you. 🫖$MRES #antioxidant #health @m2biome #evidencebasedresearch - Global Green Tea market size in 2022 - estimated $22 Billion. Wishing everybody a super weekend! 🤗 pic.twitter.com/Gbqg6YzP3C
— M2Bio Sciences (@m2bio) July 14, 2023
15 Smart Packaging Trends to Watch for in 2023 and Beyond https://t.co/qLKqiNyhy2 via @thomasnet #M2Enviro $MRES
— M2Bio Sciences (@m2bio) July 14, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. We would like to thank all of you for your messages and excitement over our crypto hacking solution, which not only solves a critical problem for the crypto industry, but the legal & medical sectors as well.
— NSAV Holding (@NSAV_Tech) July 13, 2023
In 2022, the crypto industry lost nearly $4 billion due to hacking. $NSAV and our team and partners believe that we have come up with a groundbreaking and permanent solution to the crypto hacking problem.https://t.co/njOBCZMjlj
— NSAV Holding (@NSAV_Tech) July 13, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. We hope that you all had a great 4th. of July weekend. As we announced here last week, $NSAV's latest major project is designed to be a groundbreaking and permanent solution to the crypto hacking problem.
— NSAV Holding (@NSAV_Tech) July 5, 2023
In 2022, the crypto industry lost nearly $4 billion due to hacking.https://t.co/njOBCZMjlj
— NSAV Holding (@NSAV_Tech) July 5, 2023
While the separate website, specifically for the crypto hacking solution, is being completed, please see the attached information page. As you can see, $NSAV's hacking solution not only solves a critical problem for the crypto industry, but the legal & medical sectors as well. pic.twitter.com/MRiNM3jDyB
— NSAV Holding (@NSAV_Tech) July 5, 2023
While the separate website, specifically for the crypto hacking solution, is being completed, please see the attached information page. As you can see, $NSAV's hacking solution not only solves a critical problem for the crypto industry, but the legal & medical sectors as well. pic.twitter.com/MRiNM3jDyB
— NSAV Holding (@NSAV_Tech) July 5, 2023
$NSAV shareholders, further to our earlier tweets from this morning, in the coming days, we will be launching a separate website, specifically for the crypto hacking solution. We encourage all $NSAV shareholders to stay tuned to this twitter handle for further developments.
— NSAV Holding (@NSAV_Tech) June 30, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. Our sincere apologies for not getting back to you yesterday, as we anticipated. This was due to various time zone issues with our team members. Our exciting new project attempts to solve one of the most critical problems facing the crypto industry
— NSAV Holding (@NSAV_Tech) June 30, 2023
In 2022, the crypto industry lost nearly $4 billion due to hacking. $NSAV and our team and partners believe that we have come up with a groundbreaking and permanent solution to the crypto hacking problem. https://t.co/njOBCZMRaR.
— NSAV Holding (@NSAV_Tech) June 30, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. Our sincere apologies for the delayed update on GPAG consumer behavior utility token. Management realizes that the launch is taking longer then we anticipated and here we will explain why.
— NSAV Holding (@NSAV_Tech) June 29, 2023
But first, for those $NSAV shareholders that are new to this twitter handle, we will give you a brief history on the GPAG consumer behavior utility token. The GPAG's main function will be spending rewards. The token will launch in Canada and then expand to additional countries.
— NSAV Holding (@NSAV_Tech) June 29, 2023
$NSAV believes the market for a consumer behavior utility token like GPAG is massive, based on published reports, and will be a great addition to the $NSAV Ecosystem.https://t.co/utjt4cFTih
— NSAV Holding (@NSAV_Tech) June 29, 2023
Blockchain Token membership is a new blockchain innovation focusing on consumer behavior and how the consumer market will be driven by the larger companies. This is part of the metaverse linear modelling. This will be evidenced when $NSAV releases the whitepaper.
— NSAV Holding (@NSAV_Tech) June 29, 2023
$NSAV shareholders, please refer to the study from from Mckinsey for your reference.https://t.co/bw8D2du3Ai
— NSAV Holding (@NSAV_Tech) June 29, 2023
The GPAG paid loyalty platform will function with greater efficiency and transform into a new innovative Blockchain membership platform. https://t.co/sNBzFqs2TY
— NSAV Holding (@NSAV_Tech) June 29, 2023
$NSAV's GPAG token is all about taking advantage of the consumer behavior market and converting it from a traditional consumer platform into a paid loyalty platform.
— NSAV Holding (@NSAV_Tech) June 29, 2023
The global loyalty management market is projected to grow from $5.57 billion in 2022 to $24.44 billion by 2029, at a CAGR of 23.5% in the forecasted period. This presents a major opportunity for $NSAV and its shareholders.https://t.co/2CAT4R0nnR
— NSAV Holding (@NSAV_Tech) June 29, 2023
As the GPAG consumer behavior utility token is a major project and therefore a considerable undertaking by our team in Hong Kong, we, $NSAV, needs to get it right. There have been several revisions of the whitepaper in order to improve it.
— NSAV Holding (@NSAV_Tech) June 29, 2023
In addition to several revisions to improve the GPAG token whitepaper, the $NSAV team in Hong Kong felt that the crypto audience prefers Binance chain on BEP, as Binance chain is the largest now. Therefore, they are technically switching to BEP, which is an extension of ERC 20.
— NSAV Holding (@NSAV_Tech) June 29, 2023
$NSAV shareholders, please view the link below to get an idea of the technical side of what we have been discussing this morning. This should give you an idea of the magnitude of the GPAG consumer behavior utility token project.https://t.co/hdljshBnM5
— NSAV Holding (@NSAV_Tech) June 29, 2023
Shareholders, please stay tuned for updates on the GPAG utility token project as they become available and for $NSAV's latest project, which, if successful, will solve one of the most, if not the most, critical problem facing the crypto industry today. More on this later today.
— NSAV Holding (@NSAV_Tech) June 29, 2023
$NSAV's latest project, which will be released in the coming days, will, if successful, solve one of the most, if not the most, critical problem facing the crypto industry today. Please stay tuned to this twitter handle for more on this exciting new project.
— NSAV Holding (@NSAV_Tech) June 28, 2023
NSAV Tweets recap!
Good morning $NSAV shareholders. We would like to provide you with an update on one of our upcoming major fundraising projects the GPAG (tentative token ticker), a blockchain Utility Token.
— NSAV Holding (@NSAV_Tech) June 28, 2023
But first, management realizes that $NSAV is not issuing as many press releases or tweets as we have in the past. That doesn't mean however, the team is not working as hard as ever or is any less dedicated to success and enhancing shareholder value. We definitely are.
— NSAV Holding (@NSAV_Tech) June 28, 2023
In fact, $NSAV is always looking for new projects and major acquisitions. The most recent ones are the Lithuanian Crypto Exchange & Wallet License and the joint-venture subsidiary to develop the AWC Centralized Cryptocurrency Incubator Exchange https://t.co/l1AICYwsL9 , and more.
— NSAV Holding (@NSAV_Tech) June 28, 2023
Good morning $NSAV shareholders. We would like to provide you with an update on one of our upcoming major fundraising projects the GPAG (tentative token ticker), a blockchain Utility Token.
— NSAV Holding (@NSAV_Tech) June 28, 2023
Thanks Dreamhouse!
Happy Memorial Day!